Cited by

• Immunological reactivity of a human immunodeficiency virus type I derived peptide representing a consensus sequence of the GP120 major neutralizing region V3.

  Wagner R, Modrow S, Böltz T, Fliessbach H, Niedrig M, von Brunn A, Wolf H. Wagner R, et al. Arch Virol. 1992;127(1-4):139-52. doi: 10.1007/BF01309580. Arch Virol. 1992. PMID: 1456889
• A human monoclonal antibody to a complex epitope in the V3 region of gp120 of human immunodeficiency virus type 1 has broad reactivity within and outside clade B.

  Moore JP, Trkola A, Korber B, Boots LJ, Kessler JA 2nd, McCutchan FE, Mascola J, Ho DD, Robinson J, Conley AJ. Moore JP, et al. J Virol. 1995 Jan;69(1):122-30. doi: 10.1128/JVI.69.1.122-130.1995. J Virol. 1995. PMID: 7527082 Free PMC article.
• Evidence for non-V3-specific neutralizing antibodies that interfere with gp120/CD4 binding in human immunodeficiency virus 1-infected humans.

  Kang CY, Nara P, Chamat S, Caralli V, Ryskamp T, Haigwood N, Newman R, Köhler H. Kang CY, et al. Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6171-5. doi: 10.1073/pnas.88.14.6171. Proc Natl Acad Sci U S A. 1991. PMID: 2068099 Free PMC article.
• Generation of hybrid genes and proteins by vaccinia virus-mediated recombination: application to human immunodeficiency virus type 1 env.

  Gritz L, Destree A, Cormier N, Day E, Stallard V, Caiazzo T, Mazzara G, Panicali D. Gritz L, et al. J Virol. 1990 Dec;64(12):5948-57. doi: 10.1128/JVI.64.12.5948-5957.1990. J Virol. 1990. PMID: 2243381 Free PMC article.
• Insertion of primary syncytium-inducing (SI) and non-SI envelope V3 loops in human immunodeficiency virus type 1 (HIV-1) LAI reduces neutralization sensitivity to autologous, but not heterologous, HIV-1 antibodies.

  Hogervorst E, de Jong J, van Wijk A, Bakker M, Valk M, Nara P, Goudsmit J. Hogervorst E, et al. J Virol. 1995 Oct;69(10):6342-51. doi: 10.1128/JVI.69.10.6342-6351.1995. J Virol. 1995. PMID: 7666535 Free PMC article.